Apolipoprotein E Overexpression Is Associated With Tumor Progression and Poor Survival in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Apolipoprotein E (ApoE) plays a key role in tumorigenesis and progression, such as cell proliferation, angiogenesis and metastasis. ApoE overexpression was associated with aggressive biological behaviors and poor prognosis in a variety of tumor according to previous studies. This study aimed to assess the prognostic value and explore the potential relationship with tumor progression in colorectal cancer (CRC). We collected the expression profiling microarray data from the Gene Expression Omnibus (GEO), investigated the ApoE expression pattern between the primary CRC and liver metastasis of CRC, and then explored the gene with prognostic significance based on the TCGA database. ApoE high expression was associated with poor overall survival (OS, p=0.015) and progression-free survival (PFS, p=0.004) based on the public databases. Next, ApoE expression was evaluated in two CRC cohorts by immunohistochemistry, of whom 306 cases were stage II and 201 cases were metastatic liver CRC. In the cohort of the liver metastasis, the ApoE expression was increasing in normal mucosa tissue, PCC and CLM in order. Meanwhile, the level of ApoE expression in stage II tumor sample which had no progression evidence in 5 years was lower than that in PCC of synchronous liver metastases. The high ApoE expression in PCC was an independent risk factor in both stage II (HR=2.023, [95% CI 1.297-3.154], p=0.002; HR=1.883, [95% CI 1.295-2.737], p=0.001; OS and PFS respectively) and simultaneous liver metastasis (HR=1.559, [95% CI 1.096-2.216], p=0.013; HR=1.541, [95% CI 1.129-2.104], p=0.006; OS and PFS respectively). However, the overexpression of ApoE could not predict the benefit from the chemotherapy in stage II. The study revealed that the relevance of the ApoE overexpression in CRC progression, conferring a poor prognosis in CRC patients especially for stage II and simultaneous liver metastasis. These finding may improve the prognostic stratification of patients for clinical strategy selection and promote CRC clinic outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849 · cited 1×
“A tool named GEPIA2 which is an interactive web server for analyzing the RNA sequencing expression data from the TCGA projects is used for batch TCGA data processing and visualization in this study (Tang et al., 2017).”
MethodSelf-citationHoltzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · cited 1×
“Immunohistochemical staining was performed on the slides (5 μm thick) from the TMAs, using an ApoE (pan) (D7I9N) rabbit monoclonal antibody (#13366; 1:500; Cell Signaling Technology, United States) antibody to ApoE, as it was described previously (Holtzman et al., 2000).”
MethodZheng, P., Luo, Q., Wang, W., Li, J., Wang, T., Wang, P., Chen, L., Zhang, P., Chen, H., Liu, Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0465-5 · Cited by 381
Gene Expression Profile of Gastric Carcinoma
Oue, N., Hamai, Y., Mitani, Y., Matsumura, S., Oshimo, Y., Aung, P. P., Kuraoka, K., Nakayama, H., & Yasui, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3514 · Cited by 265
Multiple pathways of apolipoprotein E signaling in primary neurons
Hoe, H., Harris, D. C., & Rebeck, G. W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.03007.x · Cited by 111
Su, W.-P., Chen, Y.-T., Lai, W.-W., Lin, C.-C., Yan, J.-J., & Su, W.-C. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.04.009 · Cited by 81 · cited 2×
“ApoE overexpression has previously been reported in gastric, lung, prostate, thyroid, ovarian, endometrial cancer and glioblastoma (Nicoll et al., 2003; Venanzoni et al., 2003; Oue et al., 2004; Ito et al., 2006; Huvila et al., 2009; Su et al., 2011).”
Background
Cited by
Colorectal liver metastasis: molecular mechanism and interventional therapy
Zhou, H., Liu, Z., Wang, Y., Wen, X., Amador, E. H., Yuan, L., Ran, X., Xiong, L., Ran, Y., Chen, W., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00922-2 · Cited by 298
Self-citationApolipoproteins: New players in cancers
He, Y., Chen, J., Ma, Y., & Chen, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1051280 · Cited by 52
Perks, C. M., Barker, R. M., Alhadrami, M., Alkahtani, O., Gill, E., Grishaw, M., Harland, A. J., Henley, P., Li, H., O’Sullivan, E., et al. (2025) · Genes · doi:10.3390/genes16030331 · Cited by 11
Locus- and Gene-Level Insights into the Inverse Association Between Alzheimer’s Disease and Cancer
Debnath, D., Housini, M., Sariya, S., Phillips, N. R., Pathak, G. A., & Barber, R. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062900 · Cited by 2
Metadata
- Authors
- Zhao, Z., Zou, S., Guan, X., Wang, M., Jiang, Z., Liu, Z., Li, C., Lin, H., Liu, X., Yang, R., Gao, Y., & Wang, X.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2018-12-13
- Volume
- 9
- Pages
- 650-650
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W2905064718
- Cited by
- 85
- References
- 7
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Apolipoprotein E Overexpression Is Associated With Tumor Progression and Poor Survival in Colorectal Cancer. https://app.cochat.ai/papers/10.3389/fgene.2018.00650
- The paper
- Zhao, Z., Zou, S., Guan, X., Wang, M., Jiang, Z., Liu, Z., Li, C., Lin, H., Liu, X., Yang, R., Gao, Y., & Wang, X. (2018). Apolipoprotein E Overexpression Is Associated With Tumor Progression and Poor Survival in Colorectal Cancer. Frontiers in Genetics. https://doi.org/10.3389/fgene.2018.00650
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.